These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35283690)

  • 1. How Various Drug Delivery Methods Could Aid in the Translation of Genome Prime Editing Technologies.
    Ivanova E
    Genet Res (Camb); 2022; 2022():7301825. PubMed ID: 35283690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy.
    Bharucha N; Arias A; Karakikes I
    Curr Opin Cardiol; 2022 Sep; 37(5):413-418. PubMed ID: 35880456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases.
    Testa LC; Musunuru K
    BioDrugs; 2023 Jul; 37(4):453-462. PubMed ID: 37314680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of Baculovirus Vectors for Multiplexed Prime Editing.
    Aulicino F; Raele RA; Harrison A; Berger I
    Methods Mol Biol; 2024; 2829():301-327. PubMed ID: 38951346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
    Bae T; Hur JW; Kim D; Hur JK
    Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
    Cai W; Luo T; Mao L; Wang M
    Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing.
    Aquino-Jarquin G
    Mol Genet Metab; 2021; 134(1-2):77-86. PubMed ID: 34391646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense RNA Interference-Enhanced CRISPR/Cas9 Base Editing Method for Improving Base Editing Efficiency in
    Zhang Y; Yun K; Huang H; Tu R; Hua E; Wang M
    ACS Synth Biol; 2021 May; 10(5):1053-1063. PubMed ID: 33720688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.
    Hansen S; McClements ME; Corydon TJ; MacLaren RE
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases.
    Yu W; Wu Z
    Adv Drug Deliv Rev; 2021 Jan; 168():181-195. PubMed ID: 32603815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime Editing: An All-Rounder for Genome Editing.
    Lu C; Kuang J; Shao T; Xie S; Li M; Zhu L; Zhu L
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of mutations in plants with prime editing.
    Hao L; Pu X; Song J
    Methods; 2021 Oct; 194():83-93. PubMed ID: 33774158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational designs of in vivo CRISPR-Cas delivery systems.
    Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
    Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.